Business PlanDecember 2009

ONE Bio Corp.

2

MissionCompany Overview Industry OverviewOperating Units Growth StrategyManagementPro forma Income Statement & Balance SheetWhy Invest?A message from Management

Presentation Agenda

Index

3

Disclaimer

This business plan includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the

“Reform Act”). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking

statements are often characterized by the terms “may,” “believes,“ “projects,” “expects,” or “anticipates,” and do not reflect historical facts.

Specific forward-looking statements contained in this business plan include, but are not limited to: our successful integration of diversified growth companies, impact

of the company’s expansion plan, and new business development success, future financial results, development and acquisition of new product lines and

services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties.

The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to:

failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors

are detailed in the Company’s regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately

and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio,

Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements

are made.

4

East meets West

Mission

ONE is committed to becoming a leader in bioengineering utilizing green processes, combining high growth, high margin Asian products with proven North American managerial expertise.

5

ONE Bio, Corp. (“ONE”) headquartered in Miami, FL, is a highly profitable company utilizing green processes to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region;

Revenue run rate, operating income and net income for 2009 have reached $41 million, $12.7 million and $8.7 million respectively;

Patented manufacturing processes allows ONE the ability to produce chemical intermediates & extracts, health products and organic and ‘green’ products that are highly sought-after worldwide;

As shown in recent medical research, ONE’s extracts are believed to fight certain critical illnesses and derive a variety of health and environmental benefits;

ONE’s products are fueled by the increased desire to become youthful, slim and healthy;

ONE is well positioned in a billion dollar industry for future growth and high shareholder returns; and

ONE has filed an application for listing on NASDAQ Capital Markets and is pending review of said application.

Company Overview

6

Bioengineering in the Asia-Pacific Region

Asia Pacific◦ Economic growth in the region continues, especially in China (projected at 8 to 9%)*;

◦ Low cost labor leads to higher profits;

◦ Asia Pacific – China region taking a greater role in driving the world economy;

◦ Private companies in the Asia Pacific – China region undervalued providing significant opportunities for ONE to acquire valuable assets at lower prices;

◦ Lower cost private companies create accretive acquisition opportunities; and

◦ Greater liquidity and more favorable listing requirements make US financial markets attractive to Asian companies.

Bioengineering◦ Growing markets due to an aging and growing population;

◦ Venture capital investment in the last few years has led to major advancements in the products and technology produced, and in particular, agricultural applications.

◦ One of the fastest growing sectors in Asia, which itself continues to experience strong growth;

◦ Tremendous advancement in technology, especially in agricultural and health products;

◦ One of the most important investment sectors of the 21st century; and*

◦ Bioengineering sector has historically outperformed the overall market.

Industry Overview

* SOURCE: asiapacific.ca

7

Complimentary divisions utilizing green processes

Chemical and Herbal Extracts (CHE)The CHE division produces chemical and herbal extracts for use in a wide range of health and wellness products.

Organic Products (OP)The OP division manufactures a variety of consumer and commercial use health and energy drinks, organic food products and fertilizers primarily based on bamboo.

Operating Units

Green friendlyONE’s operating divisions utilize green friendly processes.

8

Operating Units > CHE > Operational Overview

Fast-growing, high-tech bioengineering unit that utilizes green technology and proprietary processes to extract highly profitable health supplements, fertilizers, and pesticides from waste tobacco;

Proprietary processes and exclusive access to raw materials generate gross margins in excess of 60%;

Continuously developing health products to expand its product offering including items with solid retail potential which will further boost demand for existing products;

Markets its products throughout Asia.

Operating Units Chemical and Herbal Extracts

9

Operating Units > CHE > Product Lines

Chemical Extracts◦ High Purity Solanesol (98% purity):

Solanesol extracted from discarded tobacco leaves is the mother chemical intermediate for many high-value bio-chemicals such as Coenzyme Q10 and vitamin-K analogues

◦ CoQ10 (derivative from Solanesol): Coenzyme Q10 is a non-specific immune intensifier, which takes part in cell metabolism and respiration. Humans

naturally carry Q10, however it diminishes with aging. CoQ10 is believed to have the functions of anti-coronary heart disease, anti-aging, and ongoing medical research is showing additional pharmacological benefits

Herbal Extracts◦ Resveratrol:

Resveratrol is an active component and a powerful antioxidant extracted from Huzhang (Polygonum cuspidatum). It is extensively used for treatment of various cancers and Alzheimer's disease.

◦ 5-HTP (5-Hydroxytryptophan): 5-HTP extracted from Griffonia seed has been clinically demonstrated be effective for the treatment of depression, weight

control and insomnia.

◦ Powdered & Particulate Fertilizers: Discarded tobacco leaves are further extracted to produce organic fertilizers.

Operating Units

ONE’s extracts are the key components in hundreds of popular consumer products…

Chemical and Herbal Extracts

10

Operating Units > OP > Operational Overview

OP business specializes in highly profitable organic food and agricultural products using bamboo;

Growing OP business is divided into two parts: ◦ Organic food products; and◦ Organic agricultural products.

As organic food products they reflect the growing global trend for organic food;

ONE is the third largest bamboo producer in China; ONE is also the first bamboo company in China to gain food

safety certifications from China (HACCP), Japan (JAS) and Europe (ESFA).

ONE currently holds over 16,000 acres of organically certified bamboo land in Fujian province, one of China’s largest and most fertile areas. In addition, ONE also holds 6,000 acres of vegetable land; and

ONE’s OP business is set for rapid expansion.

Operating Units Organic Products

11

Operating Units > OP > Product Lines

Organic Food Products based on Bamboo:◦ Bamboo shoots are low in saturated fat, cholesterol and sodium yet high in dietary fiber, vitamin C,

potassium, zinc, and numerous other nutrients, making bamboo shoots ideal for weight loss and maintaining optimum health.

Organic Health Products◦ A Korean study found that the Moso bamboo leaf extract lowers cholesterol, cardiac inflammation.

Moso bamboo leaf extract is loaded with soluble and insoluble fiber and antioxidants.

◦ Moso bamboo leaf extract is used to make a caffeine-free energy drink or is infused into white rice - creating green bamboo rice with important health benefits.

Organic Fertilizers:◦ Using bamboo skins to produce organic fertilizers is highly profitable with zero material cost.

Operating Units Organic Products

12

Growth Strategy > Acquisitions

ONE’s growth strategy is based on an aggressive acquisition plan that pursues highly profitable, rapidly growing companies that exemplify strong leadership. Target companies must have the following criteria:

◦ Fast growing, cash flow positive leaders in industries where existing management has a history of profitable operating experience in the region complimented by a clear plan for growth;

◦ Bioengineering companies with proprietary technology;

◦ Repeatable and sustainable revenue streams;

◦ High barriers to entry; and

◦ Synergies with ONE’s current operating units.

ONE cultivates these new operating units by providingappropriate growth financing and strong managerialdirection.

Growth Strategy

13

Growth Strategy > Organic

ONE’s growth strategy also includes organic growth focused on the increase:◦ in land for cultivation;

◦ in product depth; and

◦ in manufacturing capacity.

ONE also intends to move from chemical extracts to actual over-the-counter products.

Growth Strategy

14

Yin – Yang: Correlative Thinking

ONE adheres to a “Yin-Yang” management strategy based on the Chinese Philosophy of “Correlative Thinking”.

The core components of this approach are: constructing a strong, balanced team; addressing the needs of investors; and realizing the

importance of diversity. ONE has successfully combined the manufacturing expertise and work ethic of the Eastern world with the

investment experience and sound management skills of the best North American companies.

The company’s team in China works in unison with North American management to insure prudent, organized growth of the core business, as well as investor transparency with an emphasis on risk management and

internal controls.

Meet our management team…

Executive Management

15

ONE Bio - Executives

Michael WeingartenChairman

Mr. Weingarten is a seasoned executive and entrepreneur with over 30 years experience in managing companies from early stage of development to multimillion dollar corporations worldwide. Mr. Weingarten has extensive experience in mergers and acquisitions, having participated in over 40 M&A transactions in his career.

Marius Silvasan, MBACEO and President

Mr. Silvasan serves as ONE’s CEO, President and Director since June 2009. Mr. Silvasan is a leader and senior executive with over 17 years experience in business development, mergers and acquisitions, strategic alliances, marketing, sales and finance. Mr. Silvasan has raised capital to fund various acquisitions and assist with organic growth.

Cris NeelyCFO

Mr. Neely serves as ONE’s CFO and Director since august 2009. Mr. Neely was previously the CFO of TelePlus World, Corp. from 2006 to 2009 and prior to TelePlus the CFO of Siemens Enterprise Networks located in Boca Raton, Florida from 1999 – 2005.

16

ONE Bio - Executives

Jerold N. Siegan J.D.General Counsel

Mr. Siegan, partner in the law firm of Arnstein & Lehr, has practiced law for more than 30 years. Mr. Siegan has extensive experience in securities & corporate law. Mr. Siegan's experience covers a broad range of industry segments, including telecommunications, software, and investment funds

Dr. Jian Ming ChanChief Scientist

Professor Chan obtained his doctrine degree in 1993 in Fudan University, now he is the Chairman of Department of Environmental Science & Engineering of Fudan University. Dr. Chan has held various senior teaching and managing positions in many universities, including Tokyo University and Osaka University in Japan and famous Fudan University in China, his positions have ranged from senior Research partner to Dean of Chemistry Faculty.

17

ONE Bio – Management Team

Min Zhao President, China

Mr. Zhao is a pioneer in the Bioengineering industry with over 10 years of experience. Mr. Zhao has served in senior positions in companies ranging from general manager to chairman. Mr. Zhao has over 20 years of business experience leading various types of companies since graduating from the Chinese People's Liberation Army University.

Jeanne ChanSr. Vice President

Ms. Chan has an extensive 17-year experience in business with focus in sales, marketing and business development. Ms. Chan held various senior executive positions during her career.

Sally OuVP of Business Development, China

Ms. Ou is a young talented entrepreneur, now she acts as an executive member of Sanming Youth Entrepreneur Association, Deputy of China National People's Congress and a member of Sanyuan District Youth Federation. Ms. Ou graduated from Beijing University and obtained her MBA degree of Hong Kong Business Management Institute.

18

ONE Bio – Management Team

Mr. Jinrong Tang VP Operations, China

Mr. Tang graduated with distinction from Zhejiang University in 1971 in Economics, and later obtained his IBM certified MBA (2000) in business. Mr. Tang was selected for 2009 Top Ten Most Outstanding Young Entrepreneurs at the Jianou People's Political Consultative Conference.

Bill CrawfordManaging Director, Investment Banking

Mr. Crawford has over thirteen years of Wall Street experience. Recently, Mr. Crawford has been a private investor and consultant to companies for capital raising. Prior to this, he was a senior analyst at Merrill Lynch and Piper Jaffray covering Wireless Services and Mobile Computing.

19

Proforma Income Statement

For the 3 months For the 9 months For the 12 months

Period Ended Sept 30, Period Ended Sept 30, Period Ended Dec 31,

  2009 2008 2009 2008 2008 2007

Revenues $9,393,907 $5,470,834 $25,913,885 $23,266,582 $34,839,128 $21,052,410

Cost of goods sold 5,186,606 2,920,804 14,857,339 13,918,331 20,534,124 11,789,269

Gross profits 4,207,301 2,550,030 11,056,546 9,348,251 14,305,004 9,263,141

Operating Expenses 1,535,934 1,333,463 3,314,938 2,616,510 3,835,126 2,352,703

Operating Profits 2,671,366 1,216,567 7,741,607 6,731,741 10,469,878 6,910,438

Non-operating expenditures 107,015 113,356 162,283 336,798 92,539 242,996

Earnings before taxes 2,564,351 1,103,211 7,579,324 6,394,943 10,377,339 6,650,380

Provision for income taxes -692,018 -568,923 -1,973,780 -1,873,964 -2,679,642 -2,225,341

Non-controlling interest -203,257 -148,678 -497,857 -500,639 -656,794 -498,079

Net income $1,669,076 $385,610 $5,107,687 $4,020,340 $7,040,903 $3,926,960

Pro-forma Earnings/share Post-Split

$0.05 $0.01 $0.16 $0.13 $0.23 $0.13

The following is a condensed pro-forma statement of operations for the 12 month period ended December 31, 2008 and 2007 and 9 and 3 months results ending Sept 30, 2009, had all of our subsidiaries been acquired prior to the reporting periods.

20

Balance Sheet

As of As of30-Sep-09 31-Dec-08

A S S E T S Unaudited UnauditedCURRENTCash and cash equivalents $ 2,581,781 $ 665,568 Receivables (Note 4) $ 10,608,627 $ 4,429,887 Inventory (Note ▪) $ 2,327,125 $ 431,569 Loans receivable (Note ▪) $ 3,585,082 - - - Prepaid expenses $ 2,109,816 - - -

$ 21,212,431 $ 5,527,024 PROPERTY, PLANT AND EQUIPMENT (Note 5) $ 5,016,172 $ 3,144,067 INTANGIBLE ASSETS (Note 7) $ 669,829 $ 159,159 LAND USE RIGHTS & OPERATING LEASES $ 15,012,491 $ 7,841,214 DEPOSIT FOR INTANGIBLE ASSETS $ 220,050 $ 161,370 GOODWILL (Note 9) $ 3,976,261 - - - RESTRICTED CASH (Note 10) $ 451,913 - - -

$ 46,559,147 $ 16,832,834 L I A B I L I T I E S

CURRENTAccounts payable and accrued liabilities $ 2,704,524 $ 2,269,594 Loans payable - current $ 5,082,169 $ 161,505 Deferred revenues $ 63,081 $ 63,081 Deferred taxes $ 45,766 - - -

$ 7,895,540 $ 2,494,180 LOANS PAYABLE, net of current $ 8,849,265 - - - DEFERRED TAXES $ 6,630 - - -

$ 16,751,435 $ 2,494,180 S H A R E H O L D E R S' E Q U I T Y

TOTAL STOCKHOLDERS’ EQUITY OF THE COMPANY $ 23,620,337 $ 13,195,384 NON-CONTROLLING INTEREST $ 6,187,375 $ 1,143,270 TOTAL EQUITY $ 29,807,712 $ 14,338,654 TOTAL LIABILITIES AND EQUITY $ 46,559,147 $ 16,832,834

21

ONE’s unified strategy is centered around prudent expansion and continued focus on profitability;

ONE’s industry is growing;

ONE’s experienced management team is focused on growing the company’s core operating units by concentrating its efforts on organic growth and strategic, accretive acquisitions;

Strong R & D team with ability to identify commercially viable products; and

Established platform for organic growth.

Why invest in ONE?

22

“We believe there are a significant number of investors that desire to participate in the accelerated growth experienced by the Asia Pacific Region. ONE intends to marry American investors wants with the capital requirements of small and medium size profitable Asia Pacific companies, while delivering strong shareholder value,” stated ONE’s Chairman Michael Weingarten.

“ONE seeks to build shareholder value through accretive acquisitions and organic growth of profitable, fast growing, bio-engineering companies. ONE intends to grow sales to over $1 billion within 3 years with a minimum $150 million in EBITDA, by providing managerial and financial support to its core holdings,” stated ONE’s Vice Chairman & CEO Marius Silvasan.

A message from Management

23

Contact Information

Marius SilvasanCEO, President & Directormsilvasan@onehcorp.com

Michael WeingartenChairman of the Boardmweingarten@onehcorp.com

Bill CrawfordManaging Director, Investment Bankingbcrawford@onehcorp.com

Contact Information

Phone: 1(877)544-2288 Email: ir@onehcorp.com

Office LocationsInternational Headquarters - United States8525 NW 53rd Terrace, Suite C101 Miami, Florida 33166, USA

Asia Headquarters - ChinaLevel 23 Citigroup Tower, No. 33 Huayuanshiqiao Road, Shanghai 200120

Other locations:ChinaNo.187,City Light Building, Hudong Road,Fuzhou City, 350001, Fujian, China

Jikou Industrial Development Zone,Sanming City, 365005, Fujian, China

Shui Xi Bei Jin Keng,Jianou City, 350001, Fujian, China

Canada1 Valleywood Dr, Suite 301,Markham, On, L3R 5L9